Abcam, ab279577, Anti-FRA1 antibody

Size: 100µL
Rabbit Polyclonal FRA1 antibody. Suitable for ICC and reacts with Human samples. Immunogen corresponding to Synthetic Peptide within Human FOSL1.
Key facts
Host species:Rabbit,
Clonality:Polyclonal,
Isotype:IgG,
Carrier free:No,
Reacts with:Human,
Applications:ICCSee reactivity dataSee the reactivity data table below for information on validated species and application combinations.,
Immunogen:Synthetic Peptide within Human FOSL1. The exact immunogen used to generate this antibody is proprietary information.P15407

Properties and Storage Information:
Form-Liquid, Purification notes-Purified by antigen affinity chromatography, Storage buffer-Constituents: PBS, Shipped at conditions-Blue Ice, Appropriate short-term storage conditions-+4°C, Appropriate long-term storage conditions-+4°C, Storage information-Do Not Freeze

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
FRA1 also known as FOS-like antigen 1 (FOSL1) is a transcription factor and a part of the AP-1 complex. It weighs about 45 kDa. This protein regulates gene expression linked to cell proliferation differentiation and survival. FRA1 shows expression in various tissues particularly in those undergoing rapid growth and development. The protein mediates immediate early gene response to diverse stimuli.
Biological function summary
In various settings FRA1 serves a role in regulating cellular responses to external signals. It forms a heterodimer with members of the JUN family to create the transcription factor AP-1 complex active in cell cycle regulation and signal transduction. This complex modulates expression of genes involved in processes like hematopoiesis and angiogenesis demonstrating its importance in physiological development and maintenance.
Pathways
The involvement of FRA1 in cellular signaling cascades stands out notably in the MAPK/ERK pathway. This pathway plays a significant role in cell growth and differentiation with FRA1 acting alongside other proteins like ERK to relay signals from surface receptors to the nucleus. Also FRA1 influences the Wnt signaling pathway which impacts cell fate decisions and embryonic development via its interactions and regulatory functions.
Researchers associate FRA1 expression with certain cancers including lung and breast cancer due to its role in controlling cell proliferation and invasion. In cancer FRA1 interacts with proteins like JUN which partner in transforming normal cells into malignant ones through the dysregulation of AP-1 activity. Its role in metastasis highlights FRA1 as a potential biomarker or therapeutic target in oncology.